Prediction and prevention of type 1 diabetes: What can be expected from genetics?

Diabetes and Metabolism

Volumn 23, Issue SUPPL. 2, 1997, Pages 29-33

  Carel, J C ^a   Lotton, C ^b   Bougneres P ^b  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b NONE

Author keywords

genetics; HLA; markers; prediabetes; screening

Indexed keywords

CONFERENCE PAPER; GENETIC MARKER; HEREDITY; HUMAN; HUMAN GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; POPULATION; SCREENING;

CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; GENETIC MARKERS; GENETIC SCREENING; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0030896866     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Thomson G, Robinson WP, Kuhner MK, et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet, 1988, 43, 799-816.
2. Thai AC, Eisenbarth GS. Natural history of IDDM. Diabetes Reviews, 1993, 1, 1-14.
3. Nepom GT. Immunogenetics and IDDM. Diabetes Reviews, 1993, 1, 93-103.
4. Davies JL, Kawaguchi Y, Bennett ST, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature, 1994, 371, 130-136.
5. She J-X. Susceptibility to type 1 diabetes : HLA-DQ and DR revisited. Immunol Today, 1996, 17, 323-329.
6. Copeman JB, Cucca F, Hearne CM, et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (JDDM7) to chromosome 2q31-q33. Nat Genet, 1995, 9, 80-85.
7. Julier C, Hyer RN, Davies J, et al. Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility. Nature, 1991, 354, 155-159.
8. Nistico L, Buzzetti R, Pritchard LE, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet, 1996, 5, 1075-1080.
9. *0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes, 1995, 44, 608-613.
10. *0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Diabetes, 1995, 44, 527-530.
11. Cerasi E, Luft R. ≪ What is inherited - what is added ≫. Hypothesis for the pathogenesis of diabetes mellitus. Diabetes, 1967, 16, 615-627.
12. Carel J-C, Boitard C, Bougneres PF. Decreased insulin response to glucose in islet cell antibody negative siblings of type 1 diabetic children. J Clin Invest, 1993, 92, 509-513.
13. Bleich D, Jackson RA, Soeldner JS, Eisenbarth GS. Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes. Diabetes Care, 1990, 13, 111-118.
14. Bingley PJ. Interaction of age, islet cell antibodies, insulin autoantibodies, and first phase-insulin response in predicting risk of progression to IDDM in ICA+ relatives. The ICARUS data set. Diabetes, 1996, 45, 1720-1728.
15. Rewers M, Bugawan TL, Norris J, et al. Newborn screening for HLA markers associated with IDDM : diabetes autoimmunity study in the young (DAISY). Diabetologia, 1996, 39, 807-812.
16. Levy-Marchal C, Tichet J, Fajardy I, Gu XF, Dubois F, Czernichow P. Islet cell antibodies in normal French schoolchildren. Diabetologia, 1992, 35, 577-582.
17. Schatz D, Krischer JP, Horne G, et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest, 1994, 93, 2403-2407.
18. Eisenbarth GS, Verge CF, Allen H, Rewers MJ. Perspective in diabetes : the design of trials for prevention of IDDM. Diabetes, 1993, 42, 941-947.
19. Carel J-C, Bougneres PF, European Prediabeles Study Group. Treatment of prediabetic patients with insulin : experience and future. Horm Res, 1996, 45S1, 44-47.
20. Riley WJ, Maclaren NK, Krischer JP, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med, 1990, 323, 1167-1172.
21. Krischer JP, Schatz D, Riley WJ, et al. Insulin and islet cell autoantibodies as time-dependent covariates in the development of insulin-dependent diabetes : a prospective study in relatives. J Clin Endocrinol Metab, 1993, 77, 743-749.
22. Bingley PJ, Christie MR, Bonifacio E, et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes, 1994, 43, 1304-1310.
23. Verge CF, Gianani R, Kawasaki E, et al. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type 1 diabeles. J Autoimmun, 1996, 9, 379-383.
24. Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000-and 40,000-Mr tryptic fragments of islet antigens in insulin dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest, 1995, 96, 1506-1511.
25. Passini N, Larigan JD, Genovese S, Appella E, Sinigaglia F, Rogge L. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc Natl Acad Sci USA, 1995, 92, 9412-9416.
26. *0602 does not prevent them. J Autoimmun, 1994, 7, 889-897.